Biosimilar Purification with Ion Exchange and Mixed-Mode Resins

Purification processes constitute more than half of the development costs for a biosimilar. Dr. Drevland presents a viable alternative workflow for the development of a HUMIRA-like biosimilar using IEX and mixed-mode resins.